Open Course 2015
Medical Industry Innovation Forum
[Theme] Is Japan really attractive to people and companies ?
November 25th, 2015 – March 22nd, 2016 (9 sessions)
18:00 – 21:00 (Reception will be held after the lecture)
Tetsumon Memorial Hall
(14th Floor, Faculty of Medicine Experimental Research Building)
- Undergraduate and graduate students (from The University of Tokyo and other universities)
- Medical Innovation Industry Institute members
- Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
- Other professionals with a strong interest in leading Innovation in the medical industry
- Regular: 45,000JPY
- Mi3 Member: 30,000JPY (It costs extra, annual membership fee 12,000 yen)
- Student: Free, for 9 lectures.
Health Care businesses and Education are becoming borderless, and are following the same global trail as sciences, technologies and economics in the past. Just as Researchers, companies and start-ups are always searching for the best location for their activities in the world, we now see patients and students doing the same. Aging demographics in developed countries and the increased influence of newly emerging countries has fueled a broad social consideration of Quality of Life improvement, including healthcare provision. Cross-border competition will further attract people and broaden the scope of QOL activities.
In this course, we discuss strategies and options of global healthcare companies. This also includes consideration of the role and policy of government, who, as the market administrator can enhance market attractiveness., In addition, there will be discussion on what we can do to make Japan one of the leading, global centres for such innovation.
Forum office within Medical Innovation Industry Institute
Presented by Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, the University of Tokyo (Professor: Hiromichi Kimura).
The Forum is sponsored by the Medical Innovation Industry Institute
Graduate School of Pharmaceutical Sciences,The University of Tokyo
IDEO Tokyo, Co-Founder and Co-Managing Director
President, Representative Director and CEO
ONO PHARMACEUTICAL CO., LTD.
COUNCILOR FOR PHAMACEUTICAL AFFAIRS MINISTER’S SECRETARIAT
Ministry of Health, Labour and Welfare
Attorney at Law
Dept. of Clinical Engineering/Innovation Promotion Office Workshop
ASO Iizuka Hospital
Medical Innovation Initiative, The University of Tokyo(Japan Biodesign)
Director / Vice President Assistant General Manager
Saiseikai Kumamoto Hospital
National Institute of Population and Social Security Research
Department of Health and Welfare Services
National Institute of Public Health
Representative Corporate Officer
Global Value & Access, Healthcare Policy, Consumer Healthcare Business, and China Business
Eisai Co., Ltd.
Vice-Minister of Health, Labour and Welfare
Executive Vice President, CMO (Chief Marketing Officer) and Member of the Board
Chairman of the Board of Directors
Nomura Holdings, Inc. / Nomura Securities Co., Ltd.
DIRECTOR & GENERAL MANAGER PLANNING DEPT., WHOLESALE BANKING UNIT
Sumitomo Mitsui Bank Corporation
Director and Unit Leader
Growth Industry Cluster Department
Sumitomo Mitsui Bank Corporation
President & COO
Vice President and Executive Officer
President & CEO,Healthcare Group and Healthcare Company
Chairman, President & CEO
President & CEO